Cargando…
Runt-Related Transcription Factor 3 Promotes Acute Myeloid Leukemia Progression
Acute myeloid leukemia (AML) is an aggressive hematological malignancy with high relapse/refractory rate. Genetic and epigenetic abnormalities are driving factors for leukemogenesis. RUNX1 and RUNX2 from the Runt-related transcription factor (RUNX) family played important roles in AML pathogenesis....
Autores principales: | Zhang, Wenwen, Ma, Qian, Long, Bing, Sun, Zhangyi, Liu, Lingling, Lin, Dongjun, Zhao, Minyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549545/ https://www.ncbi.nlm.nih.gov/pubmed/34722267 http://dx.doi.org/10.3389/fonc.2021.725336 |
Ejemplares similares
-
Expression and Prognosis Analyses of Runt-Related Transcription Factor Family in Human Leukemia
por: Sun, Cheng-Cao, et al.
Publicado: (2018) -
Research progress on molecular biomarkers of acute myeloid leukemia
por: Yin, Pei-Yuan, et al.
Publicado: (2023) -
Recent Progress on Circular RNA Research in Acute Myeloid Leukemia
por: Jamal, Muhammad, et al.
Publicado: (2019) -
Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions
por: Su, Long, et al.
Publicado: (2022) -
Expression and prognosis analyses of CASP1 in acute myeloid leukemia
por: Liu, Jing, et al.
Publicado: (2021)